Quantcast
Home > Quotes > PIRS

Pieris Pharmaceuticals, Inc. Common Stock (PIRS) Quote & Summary Data

PIRS 
$5.05
*  
0.24
4.54%
Get PIRS Alerts
*Delayed - data as of Jun. 19, 2018  -  Find a broker to begin trading PIRS now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    PIRS Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
12
Today's High / Low
$ 5.3099 / $ 5.05
Share Volume
703,404
50 Day Avg. Daily Volume
528,695
Previous Close
$ 5.29
52 Week High / Low
$ 9.75 / $ 4.27
Market Cap
272,600,813
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.16

Intraday Chart

News for PIRS

Shares Traded

Share Volume:
703,404
50 Day Avg. Daily Volume:
528,695

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.39

Trading Range

The current last sale of $5.05 is 18.27% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 5.3099 $ 9.75
 Low: $ 5.05 $ 4.27

ETFs with PIRS as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
2.61% Loncar Cancer Immunotherapy ETF (CNCR) -2.03 (-7.23%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Pieris Pharmaceuticals, Inc. was incorporated in the State of Nevada in May 2013 under the name "Marika Inc.". Pieris Pharmaceuticals, Inc. began operating the business of Pieris Pharmaceuticals GmbH, or Pieris GmbH, through a reverse acquisition on December 17, 2014. Pieris GmbH (formerly Pieris AG, a German company which was founded in 2001) continues as an operating subsidiary of the Company. Pieris Pharmaceuticals, Inc. is the sole stockholder of Pieris GmbH with its corporate headquarters located at 255 State Street, 9th Floor, Boston, Massachusetts 02109. The research facilities of Pieris GmbH are located in Freising, Germany. Pieris Australia Pty Ltd., a wholly owned subsidiary of Pieris GmbH, was formed on February 14, 2014 to conduct research and development in Australia. Pieris Pharmaceuticals Securities Corporation, a wholly owned subsidiary of Pieris Pharmaceuticals, Inc.  ... More ...  

Risk Grade

Where does PIRS fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 5.24
Open Date:
Jun. 19, 2018
Close Price:
$ 5.29
Close Date:
Jun. 19, 2018

Consensus Recommendation

Analyst Info